Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Shijiazhuang Yiling Pharmaceutical Co, Ltd. supports the battle against COVID-19 with "Lianhua Qingwen"

SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Recently, Shijiazhuang Yiling Pharmaceutical Co, Ltd. announced that the ministry of foreign affairs of the People's Republic ofChina has purchased 700,000 boxes of Lianhua Qingwen and distribute them to eachChinese embassy. The health packages ...

2020-04-13 22:25 2440

Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic

SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., announced thatLianhua Qingwen capsules (granules) have been recommended by the National Health Commission and the State Administration of Traditional Medicine of China. The ministr...

2020-04-13 21:55 1786

Thailand BOI Approves Steps to Ease COVID-19 Impact, Accelerate Investment in Medical Sector

BANGKOK, April 13, 2020 /PRNewswire/ -- The Board of Investment of Thailand (BOI) today approved a series of measures to mitigate the impact of the coronavirus or COVID-19 outbreak on business, including steps to encourage rapid investment in the manufacturing of medical equipment.

2020-04-13 21:15 3269

Thailand BOI Approves Steps to Ease COVID-19 Impact, Accelerate Investment in Medical Sector

Seegene Receives Health Canada Approval for its COVID-19 Assay

SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale inCanada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVI...

2020-04-13 21:00 2095

Gracell to Present the First-in-human, Universal TruUCAR™ GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting

SUZHOU, China and SHANGHAI, April 13, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, is pleased to announce that their first-in-human phase I data of UniversalTruUCAR™ GC027 in relapsed or refractory (R/R) T-cell acute l...

2020-04-13 21:00 1151

EmeTerm, by WAT Medical, an easy solution for Cyber Sickness

VANCOUVER, April 13, 2020 /PRNewswire/ -- WAT Medical Enterprise Ltd. conducted an investigation on solutions to cyber sickness (a form of nausea-induced vomiting). WAT Medical team has been studying has achieved positive results with the use of EmeTerm. Based on a large number of experimental te...

2020-04-13 21:00 1268

New Research Reassures & Advises Contact Lens Wearers During Coronavirus / COVID-19 Pandemic; Offers Clear Facts and Hygiene Advice

Peer-Reviewed Paper by Prominent Scientists Reinforces Need for Hand Washing, Warns that Wearing Glasses / Spectacles Does Not Reduce Risk of Infection WATERLOO, Ontario, April 13, 2020 /PRNewswire/ -- Moving swiftly to address and correct harmful myths and misinformation, a new peer-reviewed pap...

2020-04-13 20:00 4250

New Research Reassures & Advises Contact Lens Wearers During Coronavirus / COVID-19 Pandemic; Offers Clear Facts and Hygiene Advice

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today announced the appointment of Mr. Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products inAustralia, New Zealand, S. Kor...

2020-04-13 20:00 3014

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

Ascletis Receives IND Approval for its HIV Drug ASC09F

HANGZHOU and SHAOXING, China, April 13, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose C...

2020-04-13 20:00 3149

Cyient Receives ISO 13485 Quality Certification for ASIC Design and Supply

The new certification is in addition to the ISO 13485 certifications the company has had for engineering since 2009 and manufacturing since 2007 and is a testament to its expertise in developing advanced ICs for the MedTech market. HYDERABAD, India, April 13, 2020 /PRNewswire/ -- Cyient, a global...

2020-04-13 17:23 1894

Cyient Receives ISO 13485 Quality Certification for ASIC Design and Supply

VISTA Eye Specialist Going Digital to Raise Awareness on Preventable Blindness.

KUALA LUMPUR, Malaysia, April 13, 2020 /PRNewswire/ -- Amidst the global effort to stem the spread of the COVID-19 virus, includingMalaysia adopting its own Movement Control Order (MCO), VISTA Eye Specialist is not holding back their effort in its "War against Blindness" campaign. In fact, VISTA ...

2020-04-13 08:00 2837

VISTA Eye Specialist Going Digital to Raise Awareness on Preventable Blindness.

HUAWEI CLOUD and Malaysia Ministry of Health Jointly Help Sungai Buloh Hospital by Providing AI Solution to Combat COVID-19 Pandemic

KUALA LUMPUR, Malaysia, April 10, 2020 /PRNewswire/ -- Huawei Malaysia has joined hands with the Malaysia Ministry of Health to contribute Huawei Cloud AI-assisted Diagnosis solution to Sungai Buloh Hospital to empower local medical personnel with AI capabilities by providing an AI solution for C...

2020-04-10 21:31 4426

XCMG Exports Special Epidemic Prevention Equipment to the Middle East, Assisting Global Partners in Fighting COVID-19

XUZHOU, China, April 10, 2020 /PRNewswire/ -- XCMG (SHE:000425) has delivered an order of multi-functional dust suppression vehicles to theMiddle East on March 30, marking a new milestone as the company's first bulk export of the product. The deal was completed on XCMG's Machmall.com platform and...

2020-04-10 18:17 5801

XCMG Exports Special Epidemic Prevention Equipment to the Middle East, Assisting Global Partners in Fighting COVID-19

Huami Partnered with Nanshan Zhong's Team to Combat COVID-19 Coronavirus on a Joint Lab

SHENZHEN, China, April 10, 2020 /PRNewswire/ -- Huami (NYSE: HMI), announced a collaboration with China National Clinical Research Center of Respiratory Disease (NCRCRD) and Guangdong Nanshan Medical Innovation Institute, led by Dr. Nanshan Zhong, to establish a smart wearable joint laboratory. B...

2020-04-10 17:49 4202

Huami Partnered with Nanshan Zhong's Team to Combat COVID-19 Coronavirus on a Joint Lab

AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility

TOKYO, April 10, 2020 /PRNewswire/ -- AGC Inc. (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, has announced its decision to expand facilities at its synthetic pharmaceutical (*1) CDMO (*2) business subsidiary, AGC Pharma Chemicals Europe S. L. U., headquartered i...

2020-04-10 14:00 2047

Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal anti...

2020-04-10 11:39 2453

Estonia's Public and Private Sectors Come Together in E-Hackathon to Develop Innovative Solutions Admist the Crisis

TALLINN, Estonia, April 9, 2020 /PRNewswire/ -- On the day the state of emergency was declared inEstonia, a public-private e-hackathon was held as one of the first crisis responses to offer quick and feasible solutions to combat the impacts of COVID-19 outbreak. Estonia has a number of digital an...

2020-04-09 21:44 2281

JNCCN: Improving COVID-19 Safety for Cancer Patients and Healthcare Providers

PLYMOUTH MEETING, Pennsylvania, April 9, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019 (COVI...

2020-04-09 20:35 1680

Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS

GERMANTOWN, Maryland, April 9, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues a...

2020-04-09 20:00 3061

Excelra Releases COVID-19 Drug Repurposing Database to Support Global Drug Development Efforts Against Novel Coronavirus

HYDERABAD, India, April 9, 2020 /PRNewswire/ -- Excelra, a leading global data and analytics company, today announced the release of the COVID-19 Drug Repurposing Database ( https://www.excelra.com/covid-19-drug-repurposing-database/ )....

2020-04-09 19:36 2548

1 ... 697 698 699700701 702 703 ... 806